Skip to main content

ARTIVION, INC.

For the period ended Sep 30, 2026. Filed Nov 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 6, 2026

AORT$20.47-0.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Nine Months EndedSeptember 30,
20262025
Net cash flows from operating activities:
Net (loss) income$(20,019)$7,342
Adjustments to reconcile net (loss) income to net cash from operating activities:
Depreciation and amortization20,43216,701
Non-cash compensation22,80220,302
Non-cash lease expense3,9683,824
Write-down of inventories and deferred preservation costs3,7653,779
Deferred income taxes(835)(1,484)
Change in fair value of contingent consideration13,7382,390
Losses on inducement/extinguishment of debt—2,664
Gain from sale of non-financial assets—(3,500)
Other(2,089)(7,315)
Changes in operating assets and liabilities, net of acquisition:
Receivables(4,038)(924)
Inventories and deferred preservation costs(16,409)(11,563)
Prepaid expenses and other assets(4,511)(4,703)
Accounts payable, accrued expenses, and other liabilities(21,472)(7,193)
Net cash flows (used in) provided by operating activities(4,668)20,320
Net cash flows from investing activities:
Capital expenditures(31,764)(11,534)
Acquisition of Endospan, net of cash acquired(116,661)—
Payments related to sale of non-financial assets(1,500)—
Other(3,000)—
Net cash flows used in investing activities(152,925)(11,534)
Net cash flows from financing activities:
Proceeds from issuance of long-term debt, net148,875—
Repayment of debt—(207)
Proceeds from exercise of stock options and issuance of common stock4,1219,613
Payment of debt issuance costs—(1,750)
Proceeds from financing insurance premiums3,2173,117
Principal payments on short-term notes payable(2,309)(1,395)
Payment of contingent consideration(11,686)—
Other(648)(526)
Net cash flows provided by financing activities141,5708,852
Effect of exchange rate changes on cash and cash equivalents(486)2,325
(Decrease) increase in cash and cash equivalents(16,509)19,963
Cash and cash equivalents beginning of period64,90853,463
Cash and cash equivalents end of period$48,399$73,426

Condensed Consolidated Statements of Stockholders’ Equity

CommonStock · AdditionalPaid-InCapital · RetainedDeficit · Accumulated OtherComprehensive Loss · TreasuryStock · TotalStockholders'Equity
Shares · Amount · Shares · Amount
Balance at June 30, 202650,179$502$535,798$(63,591)$(12,476)(1,487)$(14,648)$445,585
Net loss———(7,926)———(7,926)
Other comprehensive income, net of tax————1,021——1,021
Equity compensation20—6,224————6,224
Exercise of options4—76————76
Employee stock purchase plan7411,419————1,420
Balance at September 30, 202650,277$503$543,517$(71,517)$(11,455)(1,487)$(14,648)$446,400
CommonStock · AdditionalPaid-InCapital · Retained Deficit · Accumulated OtherComprehensive Loss · TreasuryStock · TotalStockholders’Equity
Shares · Amount · Shares · Amount
Balance at December 31, 202549,330$493$516,604$(51,498)$(2,719)(1,487)$(14,648)$448,232
Net loss———(20,019)———(20,019)
Other comprehensive loss, net of tax————(8,736)——(8,736)
Equity compensation729722,795————22,802
Exercise of options10311,628————1,629
Employee stock purchase plan11522,490————2,492
Balance at September 30, 202650,277$503$543,517$(71,517)$(11,455)(1,487)$(14,648)$446,400

Condensed Consolidated Statements of Stockholders’ Equity (continued)

CommonStock · AdditionalPaid-InCapital · RetainedDeficit · Accumulated OtherComprehensive Loss · TreasuryStock · TotalStockholders'Equity
Shares · Amount · Shares · Amount
Balance at June 30, 202548,592$486$497,318$(60,426)$(2,828)(1,487)$(14,648)$419,902
Net income———6,502———6,502
Other comprehensive income, net of tax————541——541
Settlement of convertible senior notes20—460————460
Equity compensation16—6,135————6,135
Exercise of options18113,869————3,870
Employee stock purchase plan5311,283————1,284
Balance at September 30, 202548,862$488$509,065$(53,924)$(2,287)(1,487)$(14,648)$438,694
CommonStock · AdditionalPaid-InCapital · RetainedDeficit · AccumulatedOtherComprehensiveLoss · TreasuryStock · TotalStockholders’Equity
Shares · Amount · Shares · Amount
Balance at December 31, 202443,432$434$376,607$(61,266)$(24,927)(1,487)$(14,648)$276,200
Net income———7,342———7,342
Other comprehensive income, net of tax————22,640——22,640
Settlement of convertible senior notes4,35444102,553————102,597
Equity compensation616620,296————20,302
Exercise of options36337,365————7,368
Employee stock purchase plan9712,244————2,245
Balance at September 30, 202548,862$488$509,065$(53,924)$(2,287)(1,487)$(14,648)$438,694
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.